BICO has announced the appointment of Jesper Hagberg as its new Chief Operations & Digital Officer.
“The acquisition of Arthrosi allows us to expand our gout pipeline with a highly differentiated new asset. Pozdeutinurad has ...
Lindus Health and Quotient Sciences have announced a strategic partnership to enable enhanced patient recruitment and ...
Title21 Health Solutions, a portfolio company specialising in supporting life science regulatory needs, has joined the Blood ...
Xmoor Pharma has established a strategic collaboration with the Translational Research Office (TRO) and University College ...
Finnish biotechnology company NADMED has announced the launch of the NADMED Award 2026 in the hope of generating new ...
GRI Bio has announced positive topline results from its phase 2a clinical trial evaluating GRI-0621 in idiopathic pulmonary ...
Miranda Dini has announced the launch of GOLD Strategy & Communications, a global healthcare consultancy designed to provide ...
Genfit has announced encouraging preliminary results from its phase 1b clinical trial evaluating investigational drug GNS561 in combination with a MEK inhibitor (MEKi) in patients with KRAS mutated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback